404
Left Atrial Appendage Closure Devices Market Analysis | 2023-2028
Left Atrial Appendage Closure Devices Market Size, Share, Trends, Dynamics, Forecast, & Growth Analysis: 2023-2028
Left atrial appendage closure is a technique that assists in lowering the risk of stroke. It (LAA) is a small-sized, ear-shaped sac sited in the muscle wall of the left atrium. Left atrial appendage closure devices are used to reduce the possibility of blood clots, thus preventing stroke. They are implantable cardiac devices that are placed in the left atrial appendage for the prevention of stroke in patients.
The left atrial appendage closure devices market was estimated at USD 1.25 billion in 2022.
The left atrial appendage closure devices market is likely to reach USD 3.8 billion in 2028.
The left atrial appendage closure devices market is likely to grow at a CAGR of 20.27% during 2023-2028.
Abbott Laboratories, Aegis Medical Group, AtriCure Inc., Boston Scientific Corporation, Coherex Medical Inc., Dune Medical Devices, Johnson & Johnson Services, Inc., Lifetech Scientific, Cardia, Inc., Occlutech International AB, and St. Jude Medical, Inc. are among the key players in the market.
North America is expected to be the fastest-growing market.
The epicardial left atrial appendage closure device segment is expected to grow at a higher CAGR in the market.